NovoCure Limited (NVCR)

NovoCure Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,429	3,224	1,595	7,698	7,795	17,615
Market Cap Growth	-24.28%	102.10%	-79.27%	-1.24%	-55.75%	111.21%
Enterprise Value	1,193	2,940	1,264	7,307	7,434	17,394
Last Close Price	12.76	29.80	14.93	73.35	75.08	173.04
PE Ratio	-	-	-	-	-	889.29
PS Ratio	2.20	5.33	3.13	14.31	14.57	35.63
PB Ratio	4.19	8.95	4.40	17.45	18.99	36.97
P/TBV Ratio	4.19	8.95	4.40	17.45	18.99	36.97
P/FCF Ratio	-	-	-	816.34	133.05	209.25
P/OCF Ratio	-	-	-	250.04	94.19	177.66
PEG Ratio	-	-	-	-	-	7.19
EV/Sales Ratio	1.86	4.86	2.48	13.59	13.89	35.18
EV/EBITDA Ratio	-	-	-	-	-	451.06
EV/EBIT Ratio	-	-	-	-	-	564.54
EV/FCF Ratio	-	-	-	774.90	126.89	206.62
Debt / Equity Ratio	2.34	1.90	1.65	1.33	1.40	0.93
Debt / EBITDA Ratio	-	-	-	-	-	9.98
Debt / FCF Ratio	-	-	-	61.97	9.82	5.28
Asset Turnover	0.50	0.51	0.44	0.46	0.49	0.65
Inventory Turnover	4.02	3.72	3.78	4.25	4.41	4.15
Quick Ratio	1.49	1.37	5.46	6.73	7.29	8.39
Current Ratio	1.55	1.46	5.78	7.00	7.53	8.80
Return on Equity (ROE)	-50.60%	-46.67%	-51.52%	-21.73%	-13.16%	5.71%
Return on Assets (ROA)	-8.30%	-8.77%	-12.09%	-4.77%	-2.49%	2.51%
Return on Capital (ROIC)	-9.85%	-10.46%	-14.25%	-5.53%	-2.86%	2.96%
Return on Capital Employed (ROCE)	-29.30%	-34.60%	-23.40%	-8.60%	-4.40%	3.30%
Earnings Yield	-12.43%	-5.23%	-12.98%	-1.20%	-0.75%	0.11%
FCF Yield	-4.56%	-2.15%	-6.30%	0.12%	0.75%	0.48%
Buyback Yield / Dilution	-2.82%	-1.36%	-1.65%	-1.19%	5.00%	-11.97%

Updated Oct 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q